![Per Källblad](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Per Källblad
Vorstandsvorsitzender bei
Beactica Therapeutics AB
Profil
Per Källblad is the founder of Beactica Therapeutics AB, serving as Chief Executive Officer since 2014, with the company founded in 2006.
Former jobs include Principal at Aventis, Inc., Senior Scientist at Medivir AB from 2004 to 2006, Principal at Rhone-Poulenc Rorer, Inc., Principal at Biovitrum AB, Principal at Tibotec Virco NV, Founding Scientist at De Novo Pharmaceuticals Ltd. from 1999 to 2004, Principal at Concept Life Sciences Integrated Discovery & Dev Services Ltd., Principal at Cancer Research UK, and Principal at Roche Corp.
Education includes a doctorate from the University of Cambridge.
Aktive Positionen von Per Källblad
| Unternehmen | Position | Beginn |
|---|---|---|
Beactica Therapeutics AB
 Beactica Therapeutics AB Medical DistributorsDistribution Services Operates as a drug discovery company | Vorstandsvorsitzender | 01.01.2006 |
Ehemalige bekannte Positionen von Per Källblad
| Unternehmen | Position | Ende |
|---|---|---|
| MEDIVIR AB | Corporate Officer/Principal | - |
De Novo Pharmaceuticals Ltd.
 De Novo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Corporate Officer/Principal | - |
Tibotec Virco NV
 Tibotec Virco NV Miscellaneous Commercial ServicesCommercial Services Develops drugs and individualized disease management products | Corporate Officer/Principal | - |
Rhone-Poulenc Rorer, Inc.
 Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Corporate Officer/Principal | - |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Corporate Officer/Principal | - |
Ausbildung von Per Källblad
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
15
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Aventis, Inc.
 Aventis, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Medivir AB
 Medivir AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Commercial Services |
Tibotec Virco NV
Tibotec Virco NV Miscellaneous Commercial ServicesCommercial Services Develops drugs and individualized disease management products | Commercial Services |
De Novo Pharmaceuticals Ltd.
De Novo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Concept Life Sciences Integrated Discovery & Dev Services Ltd.
 Concept Life Sciences Integrated Discovery & Dev Services Ltd. Pharmaceuticals: MajorHealth Technology Designs, produces and supplies novel compounds | Health Technology |
Cancer Research UK
 Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Provides cancer research services | Commercial Services |
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Operates as a drug discovery company | Distribution Services |
Roche Corp. |
